CTRI/2015/02/005547已完成未知
A Pharmacological and Pharmacotherapeutical evaluation of fruit of Nagapheni (Opuntia elatior Mill.) on Pandu
Institute for post gradute teaching and research in Ayurevda gujarat ayurveda university jamnagar0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients between age of 18-60 yrs
- •Irrespective of sex
- •Diagnosed Pandu as per with classical symptomsHb% below 12gm (F) and below 13gm (M) or reduced RBC count
排除标准
- •Age less than 18 years and more than 60 years
- •Pregnancy and lactation
- •Severe Renal Hepatic Cardiac disease Cancer
- •Any continuing blood loss e g Hematemesis Melaena Bleeding piles etc
研究者
相似试验
尚未招募
3 期
To evaluate the efficacy of guduchayadi yog in the management of dislipidemiaCTRI/2024/06/069147Post Graduate Institute of Ayurveda DSRRAU Jodhpur
招募中
2 期
Pharmacotherapeutic and physicochemical evaluation of Ayabirungarajakarpam – A Siddha drug for Paandu - AnaemiaAnaemiaSLCTR/2018/035Dr. V. Elango216
招募中
2 期
Vicharchika treatment using Ayurveda medicinesCTRI/2018/02/012006SDM Ayurveda Hospital
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-CZAbbott GmbH & Co. KG100
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-DEAbbVie Deutschland GmbH & Co. KG100